Industry: Chemical & Material
Published Date: 2024-01-17
Pages: 97 Pages
Report ld: 2752003
Request Sample
Customized Report
Neomycin Sulfate API Market Size(US$)

CAGR 2024-2030
6.5%
Market Size,2030
USD 252.4
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Neomycin sulfate is an aminoglycoside antibiotic. It is used in animal and veterinary clinical treatment. It mainly has good antibacterial effect on digestive system sensitive bacteria such as E. , Streptococcus pneumoniae, Enterococcus, etc. have poor antibacterial activity. Pseudomonas aeruginosa, anaerobic bacteria, etc. are resistant to neomycin sulfate
The global Neomycin Sulfate API market was valued at US$ 162 million in 2023 and is anticipated to reach US$ 252.4 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
The API industry is an important part of the pharmaceutical industry and involves the primary production stage of drugs. In this industry, chemical, biological or other technological methods are used to synthesize, extract or manufacture the active ingredients of drugs, which are called active ingredients. APIs are the core components of medicines, and their quality and purity are critical to the safety and effectiveness of medicines. The API industry includes many aspects such as drug research and development, production, supervision and quality control. It is one of the key industries supporting the medical care system and has an important impact on human health. The development of this industry is affected by various factors such as technological progress, regulatory changes and market demand, and is highly complex and competitive.
This report aims to provide a comprehensive presentation of the global market for Neomycin Sulfate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neomycin Sulfate API.
MARKET SEGMENTATION
REPORT SCOPE
The Neomycin Sulfate API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neomycin Sulfate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neomycin Sulfate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neomycin Sulfate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Neomycin Sulfate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Neomycin Sulfate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Neomycin Sulfate API Market Overview
1.1 Product Definition
1.2 Neomycin Sulfate API Segment by Type
1.2.1 Global Neomycin Sulfate API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Veterinary Use
1.2.3 Human Use
1.3 Neomycin Sulfate API Segment by Application
1.3.1 Global Neomycin Sulfate API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Biopharmaceutical
1.3.3 Research
1.4 Global Market Growth Prospects
1.4.1 Global Neomycin Sulfate API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Neomycin Sulfate API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Neomycin Sulfate API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Neomycin Sulfate API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Neomycin Sulfate API Production Market Share by Manufacturers (2019-2024)
2.2 Global Neomycin Sulfate API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Neomycin Sulfate API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Neomycin Sulfate API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Neomycin Sulfate API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Neomycin Sulfate API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Neomycin Sulfate API, Product Offered and Application
2.8 Global Key Manufacturers of Neomycin Sulfate API, Date of Enter into This Industry
2.9 Neomycin Sulfate API Market Competitive Situation and Trends
2.9.1 Neomycin Sulfate API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Neomycin Sulfate API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Neomycin Sulfate API Production by Region
3.1 Global Neomycin Sulfate API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Neomycin Sulfate API Production Value by Region (2019-2030)
3.2.1 Global Neomycin Sulfate API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Neomycin Sulfate API by Region (2025-2030)
3.3 Global Neomycin Sulfate API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Neomycin Sulfate API Production by Region (2019-2030)
3.4.1 Global Neomycin Sulfate API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Neomycin Sulfate API by Region (2025-2030)
3.5 Global Neomycin Sulfate API Market Price Analysis by Region (2019-2024)
3.6 Global Neomycin Sulfate API Production and Value, Year-over-Year Growth
3.6.1 North America Neomycin Sulfate API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Neomycin Sulfate API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Neomycin Sulfate API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Neomycin Sulfate API Production Value Estimates and Forecasts (2019-2030)
4 Neomycin Sulfate API Consumption by Region
4.1 Global Neomycin Sulfate API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Neomycin Sulfate API Consumption by Region (2019-2030)
4.2.1 Global Neomycin Sulfate API Consumption by Region (2019-2024)
4.2.2 Global Neomycin Sulfate API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Neomycin Sulfate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Neomycin Sulfate API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Neomycin Sulfate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Neomycin Sulfate API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Neomycin Sulfate API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Neomycin Sulfate API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Neomycin Sulfate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Neomycin Sulfate API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Neomycin Sulfate API Production by Type (2019-2030)
5.1.1 Global Neomycin Sulfate API Production by Type (2019-2024)
5.1.2 Global Neomycin Sulfate API Production by Type (2025-2030)
5.1.3 Global Neomycin Sulfate API Production Market Share by Type (2019-2030)
5.2 Global Neomycin Sulfate API Production Value by Type (2019-2030)
5.2.1 Global Neomycin Sulfate API Production Value by Type (2019-2024)
5.2.2 Global Neomycin Sulfate API Production Value by Type (2025-2030)
5.2.3 Global Neomycin Sulfate API Production Value Market Share by Type (2019-2030)
5.3 Global Neomycin Sulfate API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Neomycin Sulfate API Production by Application (2019-2030)
6.1.1 Global Neomycin Sulfate API Production by Application (2019-2024)
6.1.2 Global Neomycin Sulfate API Production by Application (2025-2030)
6.1.3 Global Neomycin Sulfate API Production Market Share by Application (2019-2030)
6.2 Global Neomycin Sulfate API Production Value by Application (2019-2030)
6.2.1 Global Neomycin Sulfate API Production Value by Application (2019-2024)
6.2.2 Global Neomycin Sulfate API Production Value by Application (2025-2030)
6.2.3 Global Neomycin Sulfate API Production Value Market Share by Application (2019-2030)
6.3 Global Neomycin Sulfate API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Yichang Three Gorges Pharmaceutical
7.1.1 Yichang Three Gorges Pharmaceutical Neomycin Sulfate API Corporation Information
7.1.2 Yichang Three Gorges Pharmaceutical Neomycin Sulfate API Product Portfolio
7.1.3 Yichang Three Gorges Pharmaceutical Neomycin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Yichang Three Gorges Pharmaceutical Main Business and Markets Served
7.1.5 Yichang Three Gorges Pharmaceutical Recent Developments/Updates
7.2 Shandong Saito Biotechnology
7.2.1 Shandong Saito Biotechnology Neomycin Sulfate API Corporation Information
7.2.2 Shandong Saito Biotechnology Neomycin Sulfate API Product Portfolio
7.2.3 Shandong Saito Biotechnology Neomycin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Shandong Saito Biotechnology Main Business and Markets Served
7.2.5 Shandong Saito Biotechnology Recent Developments/Updates
7.3 Xinyu Pharmaceutical
7.3.1 Xinyu Pharmaceutical Neomycin Sulfate API Corporation Information
7.3.2 Xinyu Pharmaceutical Neomycin Sulfate API Product Portfolio
7.3.3 Xinyu Pharmaceutical Neomycin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Xinyu Pharmaceutical Main Business and Markets Served
7.3.5 Xinyu Pharmaceutical Recent Developments/Updates
7.4 Renfu Medicine
7.4.1 Renfu Medicine Neomycin Sulfate API Corporation Information
7.4.2 Renfu Medicine Neomycin Sulfate API Product Portfolio
7.4.3 Renfu Medicine Neomycin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Renfu Medicine Main Business and Markets Served
7.4.5 Renfu Medicine Recent Developments/Updates
7.5 Manus Aktteva Biopharma
7.5.1 Manus Aktteva Biopharma Neomycin Sulfate API Corporation Information
7.5.2 Manus Aktteva Biopharma Neomycin Sulfate API Product Portfolio
7.5.3 Manus Aktteva Biopharma Neomycin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Manus Aktteva Biopharma Main Business and Markets Served
7.5.5 Manus Aktteva Biopharma Recent Developments/Updates
7.6 DKSH
7.6.1 DKSH Neomycin Sulfate API Corporation Information
7.6.2 DKSH Neomycin Sulfate API Product Portfolio
7.6.3 DKSH Neomycin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 DKSH Main Business and Markets Served
7.6.5 DKSH Recent Developments/Updates
7.7 Fagron Industry
7.7.1 Fagron Industry Neomycin Sulfate API Corporation Information
7.7.2 Fagron Industry Neomycin Sulfate API Product Portfolio
7.7.3 Fagron Industry Neomycin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Fagron Industry Main Business and Markets Served
7.7.5 Fagron Industry Recent Developments/Updates
7.8 Caesar & Loretz GmbH
7.8.1 Caesar & Loretz GmbH Neomycin Sulfate API Corporation Information
7.8.2 Caesar & Loretz GmbH Neomycin Sulfate API Product Portfolio
7.8.3 Caesar & Loretz GmbH Neomycin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Caesar & Loretz GmbH Main Business and Markets Served
7.7.5 Caesar & Loretz GmbH Recent Developments/Updates
7.9 Syndesmos
7.9.1 Syndesmos Neomycin Sulfate API Corporation Information
7.9.2 Syndesmos Neomycin Sulfate API Product Portfolio
7.9.3 Syndesmos Neomycin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Syndesmos Main Business and Markets Served
7.9.5 Syndesmos Recent Developments/Updates
7.10 B Joshi Agrochem Pharma
7.10.1 B Joshi Agrochem Pharma Neomycin Sulfate API Corporation Information
7.10.2 B Joshi Agrochem Pharma Neomycin Sulfate API Product Portfolio
7.10.3 B Joshi Agrochem Pharma Neomycin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 B Joshi Agrochem Pharma Main Business and Markets Served
7.10.5 B Joshi Agrochem Pharma Recent Developments/Updates
7.11 Crystal Pharma
7.11.1 Crystal Pharma Neomycin Sulfate API Corporation Information
7.11.2 Crystal Pharma Neomycin Sulfate API Product Portfolio
7.11.3 Crystal Pharma Neomycin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Crystal Pharma Main Business and Markets Served
7.11.5 Crystal Pharma Recent Developments/Updates
7.12 Sichuan Long March Pharmaceuticals
7.12.1 Sichuan Long March Pharmaceuticals Neomycin Sulfate API Corporation Information
7.12.2 Sichuan Long March Pharmaceuticals Neomycin Sulfate API Product Portfolio
7.12.3 Sichuan Long March Pharmaceuticals Neomycin Sulfate API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Sichuan Long March Pharmaceuticals Main Business and Markets Served
7.12.5 Sichuan Long March Pharmaceuticals Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Neomycin Sulfate API Industry Chain Analysis
8.2 Neomycin Sulfate API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Neomycin Sulfate API Production Mode & Process
8.4 Neomycin Sulfate API Sales and Marketing
8.4.1 Neomycin Sulfate API Sales Channels
8.4.2 Neomycin Sulfate API Distributors
8.5 Neomycin Sulfate API Customers
9 Neomycin Sulfate API Market Dynamics
9.1 Neomycin Sulfate API Industry Trends
9.2 Neomycin Sulfate API Market Drivers
9.3 Neomycin Sulfate API Market Challenges
9.4 Neomycin Sulfate API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Neomycin Sulfate API market was valued at US$ 194 million in 2025 and is anticipated to reach US$ 299 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 143
USD 2900.00
(Single User License)
The global market for Neomycin Sulfate API was estimated to be worth US$ 194 million in 2025 and is projected to reach US$ 299 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 116
USD 3950.00
(Single User License)
The global Neomycin Sulfate API market is projected to grow from US$ 183 million in 2024 to US$ 283 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 168
USD 4900.00
(Single User License)
The global Neomycin Sulfate API market size was US$ 183 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 91
USD 4250.00
(Single User License)
The global market for Neomycin Sulfate API was estimated to be worth US$ 183 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 126
USD 3950.00
(Single User License)
The global market for Neomycin Sulfate API was valued at US$ 183 million in the year 2024 and is projected to reach a revised size of US$ 283 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published Date: 2025-02-14
Pages: 102
USD 2900.00
(Single User License)
Neomycin sulfate is an aminoglycoside antibiotic. It is used in animal and veterinary clinical treatment. It mainly has good antibacterial effect on digestive system sensitive bacteria such as E. , Streptococcus pneumoniae, Enterococcus, etc. have poor antibacterial activity. Pseudomonas aeruginosa, anaerobic bacteria, etc. are resistant to neomycin sulfate
Published Date: 2024-04-26
Pages: 113
USD 4900.00
(Single User License)
The global Neomycin Sulfate API market was valued at US$ 194 million in 2025 and is anticipated to reach US$ 299 million by 2032, at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-02-02
Pages: 143
The global market for Neomycin Sulfate API was estimated to be worth US$ 194 million in 2025 and is projected to reach US$ 299 million, growing at a CAGR of 6.5% from 2026 to 2032.
Published: 2026-02-02
Pages: 116
The global Neomycin Sulfate API market is projected to grow from US$ 183 million in 2024 to US$ 283 million by 2031, at a CAGR of 6.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 168
The global Neomycin Sulfate API market size was US$ 183 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 91
The global market for Neomycin Sulfate API was estimated to be worth US$ 183 million in 2024 and is forecast to a readjusted size of US$ 283 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 126
The global market for Neomycin Sulfate API was valued at US$ 183 million in the year 2024 and is projected to reach a revised size of US$ 283 million by 2031, growing at a CAGR of 6.5% during the forecast period.
Published: 2025-02-14
Pages: 102
Neomycin sulfate is an aminoglycoside antibiotic. It is used in animal and veterinary clinical treatment. It mainly has good antibacterial effect on digestive system sensitive bacteria such as E. , Streptococcus pneumoniae, Enterococcus, etc. have poor antibacterial activity. Pseudomonas aeruginosa, anaerobic bacteria, etc. are resistant to neomycin sulfate
Published: 2024-04-26
Pages: 113
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now